ID Biomedical Corp.

US pandemic preparedness got a boost with the Center for Biologics Evaluation and Research’s approval of Seqirus ’ Audenz, a pandemic influenza A (H5N1) vaccine destined for the national stockpile, w

Xalkori Gains Full Approval For Non-small Cell Lung Cancer FDA granted full approval for Pfizer Inc. ’s Xalkori (crizotinib) Nov. 20 for treatment of metastatic ALK-positive non-small cell lung c

FDA’s approval of GlaxoSmithKline PLC ’s Fluarix quadrivalent seasonal flu vaccine on Dec. 14 is speeding the move away from the current trivalent vaccine formulation. GSK is the second company t

This year’s flu vaccines are significantly different than last year’s, as the formulation includes two new strains. But despite the change, manufacturers expect to produce about the same number of vac